Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
CD7 is a transmembrane protein which is a member of the immunoglobulin superfamily. This protein is found on thymocytes, mature T cells, monocytes, pluripotent hematopoietic progenitor cells, early myeloid cells, and pre-B cells. It plays an essential role in T-cell interactions and also in T-cell/B-cell interaction during early lymphoid development. CD7 is an effective marker for T-cell Acute Lymphoblastic Leukemia (T-ALL). Furthermore, positive expression of CD7 is considered a marker of poor prognosis in myeloid malignancies and in cytotoxic T-cell lymphoma, while loss of CD7 indicates poor prognosis in FLT3/ITD-mutant positive acute myelogenous leukemia, adult T-cell leukemia and lymphoma, aggressive NK cell lymphoma and HTLV1.
References: The UniProt Consortium. Nucleic Acids Res. 47: D506-515 (2019); Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45, PMID:26553804; Int J Hematol 2010;91:303, PMID: 20111912; Am J Surg Pathol 2003;27:1366, PMID: 14508398;